American tegumentary leishmaniasis: Is antimonial treatment outcome related to parasite drug susceptibility?
Yardley V, Ortuno N, Llanos-Cuentas A, Chappuis F, Doncker SD, Ramirez L, Croft S, Arevalo J, Adaui V, Bermudez H, Decuypere S, Dujardin JC.
Yardley V, et al. Among authors: ortuno n.
J Infect Dis. 2006 Oct 15;194(8):1168-75. doi: 10.1086/507710. Epub 2006 Sep 8.
J Infect Dis. 2006.
PMID: 16991093
Clinical Trial.